Publication: ¿Puede el ácido acetilsalicílico a baja dosis influir el riesgo de desarrollar cáncer de mama?
Loading...
Official URL
Full text at PDC
Publication Date
2017-02
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
A nivel mundial, el cáncer de mama es la neoplasia con mayor incidencia y la segunda causa de mortalidad en mujeres. Estudios previos han demostrado una disminución del riesgo de desarrollo de cáncer colorrectal en pacientes tratados con ácido acetilsalicílico (AAS) a baja dosis, lo cual abre nuevos interrogantes para el cáncer de mama.
Breast cancer is the most frequent tumour among women and the second cause of death. Prior studies have shown that the use of low-dose aspirin can reduce the risk of colorectal cancer development and therefore this reduction could also affect to breast cancer onset.
Breast cancer is the most frequent tumour among women and the second cause of death. Prior studies have shown that the use of low-dose aspirin can reduce the risk of colorectal cancer development and therefore this reduction could also affect to breast cancer onset.